JPWO2022013307A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022013307A5
JPWO2022013307A5 JP2023502861A JP2023502861A JPWO2022013307A5 JP WO2022013307 A5 JPWO2022013307 A5 JP WO2022013307A5 JP 2023502861 A JP2023502861 A JP 2023502861A JP 2023502861 A JP2023502861 A JP 2023502861A JP WO2022013307 A5 JPWO2022013307 A5 JP WO2022013307A5
Authority
JP
Japan
Prior art keywords
fluorophenyl
chloro
amino
pyridin
pyridazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023502861A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023533849A5 (https=
JP2023533849A (ja
JP7686741B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/069649 external-priority patent/WO2022013307A1/en
Publication of JP2023533849A publication Critical patent/JP2023533849A/ja
Publication of JP2023533849A5 publication Critical patent/JP2023533849A5/ja
Publication of JPWO2022013307A5 publication Critical patent/JPWO2022013307A5/ja
Application granted granted Critical
Publication of JP7686741B2 publication Critical patent/JP7686741B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023502861A 2020-07-15 2021-07-14 Alk5阻害剤としてのピリダジニルアミノ誘導体 Active JP7686741B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20185890.9 2020-07-15
EP20185890 2020-07-15
PCT/EP2021/069649 WO2022013307A1 (en) 2020-07-15 2021-07-14 Pyridazinyl amino derivatives as alk5 inhibitors

Publications (4)

Publication Number Publication Date
JP2023533849A JP2023533849A (ja) 2023-08-04
JP2023533849A5 JP2023533849A5 (https=) 2024-07-22
JPWO2022013307A5 true JPWO2022013307A5 (https=) 2024-07-22
JP7686741B2 JP7686741B2 (ja) 2025-06-02

Family

ID=71620257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502861A Active JP7686741B2 (ja) 2020-07-15 2021-07-14 Alk5阻害剤としてのピリダジニルアミノ誘導体

Country Status (19)

Country Link
US (1) US12479826B2 (https=)
EP (1) EP4182308B1 (https=)
JP (1) JP7686741B2 (https=)
KR (1) KR20230051500A (https=)
CN (1) CN116096719B (https=)
AR (1) AR122986A1 (https=)
AU (1) AU2021307559A1 (https=)
BR (1) BR112023000588A8 (https=)
CA (1) CA3184990A1 (https=)
DK (1) DK4182308T3 (https=)
ES (1) ES2997111T3 (https=)
FI (1) FI4182308T3 (https=)
HR (1) HRP20241617T1 (https=)
HU (1) HUE069150T2 (https=)
MX (1) MX2023000521A (https=)
PL (1) PL4182308T3 (https=)
PT (1) PT4182308T (https=)
SI (1) SI4182308T1 (https=)
WO (1) WO2022013307A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7702205B2 (ja) * 2021-09-15 2025-07-03 株式会社東芝 新規アミン化合物、酸性ガス吸収剤、酸性ガスの除去方法及び酸性ガス除去
CN114957331A (zh) * 2022-04-22 2022-08-30 北京康辰药业股份有限公司 磷酸酯取代的环丙酰胺衍生喹唑啉类化合物的制备方法
WO2024180206A1 (en) 2023-03-02 2024-09-06 Chiesi Farmaceutici S.P.A. Pyridazinyl amino derivatives as alk5 inhibitors
WO2024180207A1 (en) 2023-03-02 2024-09-06 Chiesi Farmaceutici S.P.A. Pyridazinyl amino derivatives as alk5 inhibitors
KR20240159754A (ko) * 2023-04-28 2024-11-06 한국원자력의학원 N-메틸피페라진 에탄올 카바메이트(N-methylpiperazine ethanol carbamate) 구조를 포함하는 신규 화합물 및 이의 용도
WO2025132458A1 (en) 2023-12-18 2025-06-26 Chiesi Farmaceutici S.P.A. Pyridazinyl amino derivatives as alk5 inhibitors
WO2025132460A1 (en) 2023-12-18 2025-06-26 Chiesi Farmaceutici S.P.A. Pyridazinyl amino derivatives as alk5 inhibitors

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60001229T2 (de) 1999-04-09 2003-10-30 Smithkline Beecham Corp., Philadelphia Triarylimidazole
AR029803A1 (es) 2000-02-21 2003-07-16 Smithkline Beecham Plc Imidazoles sustituidos con piridilo y composiciones farmaceuticas que las comprenden
GB0007405D0 (en) 2000-03-27 2000-05-17 Smithkline Beecham Corp Compounds
EP1317450B1 (en) * 2000-09-15 2006-11-22 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
CA2423050A1 (en) 2000-09-20 2002-03-28 Ortho-Mcneil Pharmaceutical, Inc. Pyrazine derivatives as modulators of tyrosine kinases
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
JP2006503043A (ja) * 2002-09-10 2006-01-26 サイオス インク. TGFβ阻害剤
AU2004278382B2 (en) * 2003-09-30 2008-09-18 Amgen Inc. Vanilloid receptor ligands and their use in treatments
BRPI0714409A2 (pt) 2006-07-14 2013-03-12 Novartis Ag derivados de pirimidina como inibidores de alk-5
ES2375425T3 (es) 2007-07-26 2012-02-29 Novartis Ag Compuestos org�?nicos.
BRPI0817434A2 (pt) 2007-10-17 2015-06-16 Novartis Ag Composto orgânicos
AR070127A1 (es) 2008-01-11 2010-03-17 Novartis Ag Pirrolo - pirimidinas y pirrolo -piridinas
MX2010007604A (es) 2008-01-11 2010-08-02 Novartis Ag Pirimidinas como inhibidores de cinasa.
US8343966B2 (en) 2008-01-11 2013-01-01 Novartis Ag Organic compounds
EA201001687A1 (ru) 2008-04-29 2011-06-30 Новартис Аг Производные имидазопиридина в качестве ингибиторов активиноподобной рецепторной киназы ( alk-4 или alk-5 )
CN102596200A (zh) * 2009-11-07 2012-07-18 默克专利有限公司 作为TGF-β受体激酶抑制剂的杂芳基氨基喹啉类
DK2731949T3 (en) 2011-07-13 2018-06-14 Tiumbio Co Ltd 2-PYRIDYL-SUBSTITUTED IMIDAZOLS AS ALK5 AND / OR ALK4 INHIBITORS
HRP20201384T1 (hr) * 2014-01-01 2020-11-27 Medivation Technologies Llc Spojevi i postupci njihove upotrebe
US20200247812A1 (en) * 2018-07-10 2020-08-06 Integral Biosciences Private Limited Heterocyclic compounds and methods of use

Similar Documents

Publication Publication Date Title
HRP20241617T1 (hr) Piridazinilni amino-derivati kao inhibitori alk5
JP7284830B2 (ja) タンパク質チロシンホスファターゼ阻害剤
JP6236173B2 (ja) 脊髄性筋萎縮症を処置するための化合物
JP2021506858A5 (https=)
CN102762570B (zh) 作为jak抑制剂的吡唑衍生物
RU2014120374A (ru) Имидазопиридазины
JP2019535664A5 (https=)
JP2020510092A5 (https=)
US11267804B2 (en) (R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity
JPWO2023064857A5 (https=)
RU2016151315A (ru) Некоторые ингибиторы протеинкиназы
JPWO2023287896A5 (https=)
US10112945B2 (en) Fused quinoline compunds as PI3K, mTOR inhibitors
JP2018525377A5 (https=)
KR20190040054A (ko) 이환식 함질소 헤테로환 화합물
JPWO2023066350A5 (https=)
KR20220028075A (ko) 티로신 키나제 비-수용체 1 (tnk1) 억제제 및 그의 용도
JPWO2022013307A5 (https=)
CN119630669A (zh) 硫代的戊二酰亚胺基异吲哚啉酮衍生物、含有其的双功能蛋白降解剂及它们的应用
WO2024026056A2 (en) Heteroaryl compounds as egfr inhibitors and their uses
CN110156782B (zh) 作为pi3k/mtor抑制剂的吡啶基取代的稠合喹啉化合物
JP2015512427A5 (https=)
RU2014144285A (ru) Карбоксамидные соединения и их применение в качестве ингибиторов кальпаина v
US10130631B2 (en) CML therapeutic agents with reduced drug-resistance and side-effect comprising 1,6-disubstituted indole compounds
JPWO2020207991A5 (https=)